Get the Stockscreener App
10.67
0.56%
-0.06
After Hours:
10.86
0.19
+1.78%
Ardent Health Inc stock is traded at $10.67, with a volume of 345.46K.
It is down -0.56% in the last 24 hours and up +8.43% over the past month.
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S and operating in eight growing mid-sized urban markets across six states Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The main focus on people and investments in services and technologies.
See More
Previous Close:
$10.73
Open:
$10.65
24h Volume:
345.46K
Relative Volume:
0.65
Market Cap:
$1.53B
Revenue:
$6.32B
Net Income/Loss:
$230.14M
P/E Ratio:
11.12
EPS:
0.9598
Net Cash Flow:
$256.03M
1W Performance:
+0.28%
1M Performance:
+8.43%
6M Performance:
+30.60%
1Y Performance:
+0.66%
1-Day Range:
$10.27
$10.71
1-Week Range:
$10.27
$11.68
52-Week Range:
$7.71
$15.48
Ardent Health Inc Stock (ARDT) Company Profile
Name
Ardent Health Inc
Sector
Industry
Phone
(615) 296-3000
Address
340 SEVEN SPRINGS WAY, BRENTWOOD
Compare ARDT vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARDT
Ardent Health Inc
|
10.68 | 1.57B | 6.32B | 230.14M | 256.03M | 0.9598 |
HCA
Hca Healthcare Inc
|
402.58 | 86.43B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
254.84 | 20.96B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
240.11 | 15.17B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
25.67 | 13.36B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
111.08 | 11.30B | 6.07B | 793.80M | 464.40M | 5.9914 |
Ardent Health Inc Stock (ARDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-14-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Sep-10-25 | Initiated | UBS | Buy |
| Jul-16-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| Nov-06-24 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-12-24 | Initiated | BofA Securities | Buy |
| Aug-12-24 | Initiated | Citigroup | Buy |
| Aug-12-24 | Initiated | JP Morgan | Neutral |
| Aug-12-24 | Initiated | Leerink Partners | Outperform |
| Aug-12-24 | Initiated | Loop Capital | Buy |
| Aug-12-24 | Initiated | Mizuho | Outperform |
| Aug-12-24 | Initiated | Morgan Stanley | Overweight |
| Aug-12-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-12-24 | Initiated | Stephens | Overweight |
| Aug-12-24 | Initiated | Truist | Buy |
View All
Ardent Health Inc Stock (ARDT) Latest News
Ardent Health, Inc. (ARDT) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Ardent Health Partners Inc (ARDT) Institutional Confidence - TradingKey
Ardent Health Partners Inc (ARDT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ardent Health Partners Inc (ARDT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ardent Health, Inc. (ARDT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Ardent Health Partners Inc (ARDT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-07-23 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Shareholders to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
Ardent Health reaches 1 million AI-assisted patient encounters By Investing.com - Investing.com Canada
Ardent Health surpasses 1 million patient encounters supported by ambient AI - Yahoo Finance
ARDT|Ardent Health Partners Inc|Price:10.829|Chg%:+0.409 - TradingKey
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Ardent Health (ARDT) Hovers Near Support as Range-Bound Trading PersistsETF Outflow Streak - dars.gov.et
Ardent Health (ARDT) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2026-07-19 | Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Shareholders to Inquire about Securities Investigation | NYSE:ARDT | Press Release - Stockhouse
Press Release: Ardent Health Announces Second Quarter 2026 Results Conference Call and Webcast Date - Moomoo
Ardent Health Announces Second Quarter 2026 Results Conference Call and Webcast Date - marketscreener.com
Ardent Health's Q2 Results Call Replay Runs Through Aug. 19 - Stock Titan
Ardent Health updates financial calendar with quarterly earnings call and webcast schedule - Bitget
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Shareholders to Connect - ACCESS Newswire
Ardent Health Price Target Cut to $12.00/Share From $13.00 by Truist Securities - Moomoo
BofA Securities Maintains Ardent Health(ARDT.US) With Sell Rating, Announces Target Price $9 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Truist Financial Maintains Ardent Health(ARDT.US) With Buy Rating, Announces Target Price $12 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Price to earnings forward of Ardent Health, Inc. – NYSE:ARDT - TradingView
2026-07-12 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Investors to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RBC Capital Maintains Ardent Health(ARDT.US) With Buy Rating, Cuts Target Price to $12 - Moomoo
RBC Adjusts Price Target on Ardent Health Partners to $12 From $13, Maintains Outperform Rating - Moomoo
ARDT Q1 2026 Earnings: EPS Beats Estimates by 48.62% Despite Revenue Uncertainty, Stock Declines 6.19%High Growth Earnings - DonanımHaber
BofA Securities Adjusts Ardent Health Partners Price Target to $9.50 From $9 - Moomoo
Ardent Health (ARDT) Stephens Annual Investment Conference Summary - Quartr
Does Ardent Health's (ARDT) Russell Growth Exit Hint At A Shift In Its Investor Base? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Investors to Connect - ACCESS Newswire
Ardent Health (ARDT) Slips Slightly as Stock Tests Key Support LevelsCall Resistance - DonanımHaber
ARDT Deadline: Rosen Law Firm Urges Ardent Health, Inc. (NYSE: AR - The National Law Review
Ardent Health Inc. (ARDT) Q1 2026 Earnings: Strong EPS Surprise Drives Share Price GainsAnalyst Coverage Count - dars.gov.et
ARDTArdent Health Inc Options - Finviz
Form 4 Ardent Health Partners LLC For: 2 July By Investing.com - Investing.com Canada
Ardent Health (ARDT) CEO Dave Caspers awarded 103,653 RSUs in equity grant - Stock Titan
Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare
Is Ardent Health Poised For A Turnaround After A Plunge From Its 52-Week High? - RTTNews
Do options traders know something about Ardent Health stock we don't? - MSN
Ardent Health CEO Separation Agreement Finalizes Leadership Transition - The Globe and Mail
Ardent Health (NYSE: ARDT) files former CEO separation agreement - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
2026-06-30 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Stockholders to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
Ardent Health, Inc.(NYSE:ARDT) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Ardent Health Inc Stock (ARDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ardent Health Inc Stock (ARDT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| LUMSDAINE ALFRED | Chief Financial Officer |
Jun 05 '26 |
Buy |
8.81 |
10,000 |
88,100 |
329,183 |
0.03%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):